Review article: pharmacotherapy for alcohol dependence – the why, the what and the wherefore

  title={Review article: pharmacotherapy for alcohol dependence – the why, the what and the wherefore},
  author={Ee Teng Goh and M Y Morgan},
  journal={Alimentary Pharmacology \& Therapeutics},
The development of alcohol dependence is associated with significant morbidity and mortality. For the majority of affected people the most appropriate goal, in terms of drinking behaviour, is abstinence from alcohol. Psychosocial intervention is the mainstay of the treatment but adjuvant pharmacotherapy is also available and its use recommended. 
Impact of Alcohol Use Disorder Treatment on Clinical Outcomes Among Patients With Cirrhosis
This work characterized the use of and outcomes associated with AUD treatment in patients with cirrhosis and their impact on clinical outcomes in this population.
[Pharmacotherapy of alcohol withdrawal: update and new developments].
In the light of the currently running revision of the German guidelines for the diagnosis and treatment of alcohol related disorders, an update on the pharmacotherapy of alcohol dependence is presented.
Diagnosis and Management of Alcohol Use Disorder in Patients with Liver Disease: Lights and Shadows
The diagnosis and the management of alcohol use disorder in patients with liver disease are critically discussed and psychosocial intervention became crucial in patients considering the limited pharmacological choice.
Long-term pharmacotherapy aimed at maintaining abstinence or reducing alcohol intake in alcohol-dependent individuals. Guidelines from the Section of Pharmacotherapy of Polish Society for Research on Addictions (PTBU) and the Section of Psychopharmacology of Polish Psychiatric Association (PTP) – 20
The article presents update of the 2013 Guidelines of the Pharmacotherapy Section of the Polish Society for Research on Addictions (PTBU) and the Psychopharmacology Section (PTP) on long-term pharmacotherapy aimed at maintaining abstinence or reducing alcohol intake in adult alcohol-dependent patients.
Alcohol addiction - the safety of available approved treatment options
All approved medications are valid tools for the treatment of AUD in patients without advanced liver disease, but for some drugs, attention should be paid to patients with renal failure and medications may be used with caution, adjusting the dosage according to kidney function.
Alcoholism and nutrition: a review of vitamin supplementation and treatment.
  • M. J. Lewis
  • Medicine
    Current opinion in clinical nutrition and metabolic care
  • 2020
There are very significant findings with individual vitamin supplementation and combinations that show promise of the understanding of the role of vitamins in the disease of alcoholism and its treatment.
Baclofen in the Treatment of Patients With Alcohol Use Disorder and Other Mental Health Disorders
A narrative review of the scientific literature related to the use of baclofen in AUD, both in patients with and without concomitant psychiatric disorders indicates that the most frequent psychiatric comorbidities in patients affected by AUD undergoing bacl ofen treatment are anxiety and mood disorders.
Selecting an appropriate alcohol pharmacotherapy: review of recent findings.
Several RCTs on baclofen do not support the use of bacl ofen for treatment of AUD, but encouraging results have been reported for topiramate, gabapentin and also varenicline, which might be useful in patients with comorbid nicotine dependence.
Pharmacogenetics of alcohol addiction: current perspectives
A review of the literature on pharmacogenetic biomarkers development for the pharmacotherapy personalization reveals that today the evidence base concerning these biomarkers is still insufficient, and now the researches with the design of randomized controlled trials and meta-analysis investigating the effect of the SNPs as biomarkers on the therapy efficacy are available for naltrexone only.


Pharmacotherapy for Alcohol Dependence: The 2015 Recommendations of the French Alcohol Society, Issued in Partnership with the European Federation of Addiction Societies
The latest French good practice recommendations for the screening, prevention, and treatment of alcohol misuse were recently published and this article aims to synthesize the GPRs focused on the pharmacotherapy of alcohol dependence.
Acute alcohol toxicity and withdrawal in the emergency room and medical admissions unit.
This article focuses on the management of alcohol intoxication, with particular emphasis on aggressive and possibly violent behaviour; alcohol withdrawal; fitting; and the prevention and treatment of Wernicke's encephalopathy.
Acamprosate for alcohol dependence?
Acamprosate appears to be an effective and safe treatment strategy for supporting continuous abstinence after detoxification in alcohol dependent patients and should be valued against the background of the relapsing nature of alcoholism and the limited therapeutic options currently available for its treatment.
Barriers to the use of medications to treat alcoholism.
It is indicated that medications to treat alcoholism must overcome numerous barriers before becoming widely accepted.
Pharmacotherapy of alcoholic liver disease in clinical practice
A large number of patients with a history of alcohol‐related liver disease and a literature review showed clear trends in prognosis, particularly in the long‐term management of these patients are thought to be at risk of dying from liver disease.
Safety and Tolerability of Pharmacological Treatment of Alcohol Dependence: Comprehensive Review of Evidence
Five drugs, including an extended-release injectable suspension of naltrexone, have different safety profiles that need to be balanced with the treatment objective (initiation or continuation of abstinence, or reduction of drinking), individual patient preferences and comorbid conditions.
The efficacy of disulfiram for the treatment of alcohol use disorder.
Supervised treatment with disulfiram has some effect on short-term abstinence and days until relapse as well as number of drinking days when compared with placebo, none, or other treatments for patients with alcohol dependency or abuse.
Metadoxine in the Treatment of Acute and Chronic Alcoholism: A Review
Preclinical and clinical results obtained using metadoxine in acute and chronic alcohol intoxication are reported and the drug seems to be safe.